Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2026
X4 Pharmaceuticals reports third-quarter 2026 results
X4 Pharmaceuticals reported financial results for the third quarter ended September 30, 2026, including revenue of $2.9 million and a net loss of $20.2 million for the three months.
2026
X4 secures term loan facility of up to $150 million
X4 Pharmaceuticals said it secured a senior term loan facility of up to $150 million with K2 HealthVentures LLC, replacing a prior loan agreement.
2019
X4 Pharmaceuticals appoints William E. Aliski to its board
X4 Pharmaceuticals appointed William E. Aliski to its Board of Directors, effective September 18, 2019.